Ocular Therapeutix, Inc.
NASDAQOcular Therapeutix reported Q1 results on May 5 that landed below expectations on every line — EPS of -$0.40 missed the -$0.33 estimate, and revenue of $10.8 million trailed the $12.6 million consensus. The stock slipped just 0.6% on the day, suggesting the miss was absorbed quickly, but the week's more interesting story is what sits behind the headline: shorts have been rebuilding…
Snapshot as of 7 May 2026
Ocular Therapeutix reported Q1 results on May 5 that landed below expectations on every line — EPS of -$0.40 missed the -$0.33 estimate, and revenue of $10.8 million trailed the $12.6 million consensus. The stock…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for OCUL — free to start on ORTEX.
Sign up for free →Open OCUL on ORTEX